Serina Therapeutics Financials - Benzinga

Serina Therapeutics Inc

SERAMEX

Trade with Public

Trade with Public

$2.46

-0.06-2.38%

At close: Aug 28, 5:00 PM EST

$2.39

-0.07-2.85%

After Hours: 4:34 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Serina Therapeutics Financials

Serina Therapeutics (SER) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Serina Therapeutics Q2 EPS $(0.55) Misses $(0.47) Estimate, Sales $130.000K, Same YoY

Serina Therapeutics (AMEX:SER) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.47) by 19.57 percent. This is a 16.67 percent increase over losses of $(0.66) per share

Benzinga Newsdesk

PRO
Serina Therapeutics Q1 EPS $(0.58) Misses $(0.44) Estimate

Serina Therapeutics (AMEX:SER) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.44) by 31.82 percent. This is a 18.37 percent decrease over losses of $(0.49) per share

Benzinga Newsdesk

PRO
Serina Therapeutics Q4 EPS $(0.31) Beats $(0.46) Estimate

Serina Therapeutics (AMEX:SER) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.46) by 32.61 percent. This is a 29.17 percent decrease over losses of $(0.24) per share from

Benzinga Newsdesk

Stock Market Today: Futures Drop Ahead Of 'Triple Witching' Session As Iran Threatens 'Zero Restraint'— FedEx, Super Micro In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the story.) U.S. stock futures declined on Friday following Thursday’s declines. Futures of the major benchmark indices were lower.

Rishabh Mishra

Gold Tumbles Over 6%; Accenture Earnings Top Views

Avi Kapoor

PRO
Serina Therapeutics Q3 EPS $(0.45) Beats $(0.53) Estimate

Serina Therapeutics (AMEX:SER) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.53) by 15.09 percent. This is a 446.15 percent decrease over earnings of $0.13 per share from

Benzinga Newsdesk